Recipharm has appointed Bernard Pluta president of Development Services to lead its new global development organization.

The newly established position forms part of the ongoing transformation of Recipharm’s Development Services, in which a total of 400 employees across six countries are united to deliver a comprehensive development offering. The business area will cover end to end development services, ranging from development of the active compound to providing dossiers for marketing authorization applications in all major geographies. 

Bernard Pluta is currently the general manager of Recipharm’s manufacturing and development operations in Pessac, France and recently led a Group wide project focusing on optimising and coordinating Recipharm’s extensive development capacities in Sweden, Italy, France, US, India and Israel.

Thomas Eldered said, “I am delighted to announce the appointment of Bernard Pluta as president, Development Services. Bernard has managed our operations in Pessac with great success. His industry expertise and solid business competence will play a key role in transforming our development services and ensuring a seamless end to end offering. By providing a wide range of development services we are well positioned to manage challenging projects and complexity on behalf of our customers.”

Bernard Pluta has previously held executive positions with Theramex, Merck Serono and Teva. He also ran his own CMO consultancy business before joining Recipharm in 2015.